Continuing to advance the pipeline and remain on-track to engage with the FDA on TP-04 (Papulopustular Rosacea) and TP-05 ...

XDEMVY is indicated for the treatment of Demodex blepharitis. Most common side effects: The most common side effect in clinical trials was stinging and burning in 10% of patients. Other side effects ...

A pharmacist has warned that allergy sufferers could be in for a difficult time this autumn and winter. Allergies affecting ...

TP-03 for the treatment of Demodex blepharitis and meibomian gland disease; NBTXR3 for the treatment of head and neck squamous cell carcinoma, and solid tumor; Infigratinib for the treatment of second ...

I've had a genital itch for years. I take prescription drugs which have itchiness listed as a side effect, but I can't ...

The source of the TVD may be as benign as blepharitis or as ominous as a heralding ... on the priorities involved in the investigation and treatment of patients presenting with ischemic or ...

This clear documentation will guide the clinician in comparing previous to subsequent TVDs in the same patient and may aid in the assessment of the efficacy of the treatment modalities administered.

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new ...

Detailed price information for Tarsus Pharmaceuticals Inc (TARS-Q) from The Globe and Mail including charting and trades.

Though it’s the most common skin condition in the United States, determining the best acne treatment for your skin is still challenging. Acne treatments include prescription medications ...